ImmunoPrecise Antibodies Ltd (IPA)
0.3425
-0.01
(-1.69%)
USD |
NASDAQ |
Nov 22, 13:40
ImmunoPrecise Antibodies Market Cap: 9.561M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 9.726M |
| November 20, 2024 | 10.77M |
| November 19, 2024 | 11.39M |
| November 18, 2024 | 11.49M |
| November 15, 2024 | 12.41M |
| November 14, 2024 | 12.84M |
| November 13, 2024 | 13.40M |
| November 12, 2024 | 13.12M |
| November 11, 2024 | 12.50M |
| November 08, 2024 | 12.28M |
| November 07, 2024 | 12.28M |
| November 06, 2024 | 10.98M |
| November 05, 2024 | 11.77M |
| November 04, 2024 | 12.00M |
| November 01, 2024 | 11.65M |
| October 31, 2024 | 13.32M |
| October 30, 2024 | 13.59M |
| October 29, 2024 | 15.12M |
| October 28, 2024 | 16.07M |
| October 25, 2024 | 18.93M |
| October 24, 2024 | 16.05M |
| October 23, 2024 | 14.95M |
| October 22, 2024 | 14.16M |
| October 21, 2024 | 14.94M |
| October 18, 2024 | 15.07M |
| Date | Value |
|---|---|
| October 17, 2024 | 15.05M |
| October 16, 2024 | 15.66M |
| October 15, 2024 | 15.91M |
| October 14, 2024 | 16.10M |
| October 11, 2024 | 16.41M |
| October 10, 2024 | 16.47M |
| October 09, 2024 | 16.50M |
| October 08, 2024 | 17.55M |
| October 07, 2024 | 17.31M |
| October 04, 2024 | 17.45M |
| October 03, 2024 | 15.14M |
| October 02, 2024 | 16.27M |
| October 01, 2024 | 16.32M |
| September 30, 2024 | 17.84M |
| September 27, 2024 | 18.08M |
| September 26, 2024 | 18.70M |
| September 25, 2024 | 18.98M |
| September 24, 2024 | 18.06M |
| September 23, 2024 | 17.94M |
| September 20, 2024 | 18.70M |
| September 19, 2024 | 18.84M |
| September 18, 2024 | 18.42M |
| September 17, 2024 | 16.16M |
| September 16, 2024 | 15.13M |
| September 13, 2024 | 18.70M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.561M
Minimum
Nov 22 2024
314.32M
Maximum
Dec 29 2020
91.88M
Average
91.92M
Median
Jun 24 2020
Market Cap Benchmarks
| Aurinia Pharmaceuticals Inc | 1.266B |
| Edesa Biotech Inc | 7.014M |
| Lexaria Bioscience Corp | 33.04M |
| Xenon Pharmaceuticals Inc | 3.170B |
| ESSA Pharma Inc | 80.75M |
Market Cap Related Metrics
| PS Ratio | 0.5052 |
| PEG Ratio | -0.0178 |
| Price to Book Value | 0.4031 |
| Price | 0.3425 |
| Earnings Yield | -227.8% |
| PEGY Ratio | -0.0178 |